selected publications
-
The synthetic phospholipid C8-C1P determines pro-angiogenic and pro-reparative features in human macrophages restraining the proinflammatory M1-like phenotype.
Frontiers in immunology.
2023
Academic Article
GET IT
Times cited: 147 -
Next generation patient derived tumor organoids.
Translational research : the journal of laboratory and clinical medicine.
2022
Review
GET IT
Times cited: 1 -
An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases.
2022
GET IT
Times cited: 2 -
Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia.
Haematologica.
2020
Letter
GET IT
Times cited: 3 -
Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF.
Frontiers in immunology.
2020
Academic Article
GET IT
Times cited: 4 -
The effect of ibrutinib on neutrophil and γδ T cell functions.
Leukemia & lymphoma.
2020
Academic Article
GET IT
Times cited: 12 -
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Cancer immunology, immunotherapy : CII.
2020
Academic Article
GET IT
Times cited: 4 -
Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood.
2019
GET IT
Times cited: 2 -
Neglected players: Tumor associated neutrophils involvement in chronic lymphocytic leukemia progression.
Oncotarget.
2019
Editorial Article
GET IT
Times cited: 2 -
Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis.
Blood cancer journal.
2018
Letter
GET IT
Times cited: 24 -
Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16high CD62Ldim immunosuppressive subset.
International journal of cancer.
2018
Academic Article
GET IT
Times cited: 14 -
Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.
Haematologica.
2018
Letter
GET IT
Times cited: 13 -
Laurus nobilis L. Extracts against Paenibacillus larvae: Antimicrobial activity, antioxidant capacity, hygienic behavior and colony strength.
Saudi journal of biological sciences.
2018
Academic Article
GET IT
Times cited: 22 -
Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.
Scientific reports.
2017
Academic Article
GET IT
Times cited: 13 -
Modulation of Dendritic Cell Apoptosis and CD8+ Cytotoxicity by Histamine: Role of Protein Kinase C.
Mediators of inflammation.
2017
Academic Article
GET IT
Times cited: 5 -
Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.
Haematologica.
2017
Letter
GET IT
Times cited: 7 -
Protein malnutrition during fetal programming induces fatty liver in adult male offspring rats.
Journal of physiology and biochemistry.
2017
Academic Article
GET IT
Times cited: 8 -
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.
Cancer immunology, immunotherapy : CII.
2016
Academic Article
GET IT
Times cited: 11 -
Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).
Cancer immunology, immunotherapy : CII.
2016
Academic Article
GET IT
Times cited: 37 -
Soluble RANKL production by leukemic cells in a case of chronic lymphocytic leukemia with bone destruction.
Leukemia & lymphoma.
2016
Letter
GET IT
Times cited: 4 -
Ibrutinib impairs the phagocytosis of rituximab-coated leukemic cells from chronic lymphocytic leukemia patients by human macrophages.
Haematologica.
2015
Letter
GET IT
Times cited: 54 -
The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.
Journal of immunology (Baltimore, Md. : 1950).
2014
Academic Article
GET IT
Times cited: 18